These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 2594826)

  • 41. Chitosan drug binding by ionic interaction.
    Boonsongrit Y; Mitrevej A; Mueller BW
    Eur J Pharm Biopharm; 2006 Apr; 62(3):267-74. PubMed ID: 16275050
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Preparation and in vitro characterization of solid dispersion floating tablet by effervescent control release technique with improved floating capabilities.
    Singhal P; Kaushik RD; Kumar VJ; Verma A; Gupta P
    Pak J Pharm Sci; 2016 Sep; 29(5):1661-1670. PubMed ID: 27731827
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Geometry of modified release formulations during dissolution--influence on performance of dosage forms with diclofenac sodium.
    Dorożyński P; Kulinowski P; Jamróz W; Juszczyk E
    Int J Pharm; 2014 Dec; 477(1-2):57-63. PubMed ID: 25311175
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preparation and characterization by morphological analysis of diclofenac/PEG 4000 granules obtained using three different techniques.
    Rodriguez L; Cavallari C; Passerini N; Albertini B; González-Rodríguez M; Fini A
    Int J Pharm; 2002 Aug; 242(1-2):285-9. PubMed ID: 12176265
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Buoyant sustained release granules based on chitosan.
    Inouye K; Machida Y; Sannan T; Nagai T
    Drug Des Deliv; 1989 Jan; 4(1):55-67. PubMed ID: 2775446
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of properties microcrystalline chitosan as a drug carrier. Part 1. In vitro release of diclofenac from mictocrystalline chitosan hydrogel.
    Bodek KH
    Acta Pol Pharm; 2000; 57(6):431-40. PubMed ID: 11243249
    [TBL] [Abstract][Full Text] [Related]  

  • 47. STUDYING THE IMPACT OF FORMULATION AND PROCESSING PARAMETERS ON THE RELEASE CHARACTERISTICS FROM HYDROXYPROPYL METHYLCELLULOSE MATRIX TABLETS OF DICLOFENAC.
    Elzayat EM; Abdel-Rahman AA; Ahmed SM; Alanazi FK; Habib WA; Sakr A
    Acta Pol Pharm; 2016; 73(2):439-52. PubMed ID: 27180437
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effect of preparation method on properties of orally disintegrating tablets made by phase transition.
    Kuno Y; Kojima M; Ando S; Nakagami H
    Int J Pharm; 2008 May; 355(1-2):87-92. PubMed ID: 18182258
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation.
    Sano S; Iwao Y; Kimura S; Itai S
    Int J Pharm; 2011 Sep; 416(1):252-9. PubMed ID: 21763765
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Fast-melting tablets based on highly plastic granules.
    Fu Y; Jeong SH; Park K
    J Control Release; 2005 Dec; 109(1-3):203-10. PubMed ID: 16260059
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Application of design of experiments and multilayer perceptrons neural network in the optimization of diclofenac sodium extended release tablets with Carbopol 71G.
    Ivić B; Ibrić S; Cvetković N; Petrović A; Trajković S; Djurić Z
    Chem Pharm Bull (Tokyo); 2010 Jul; 58(7):947-9. PubMed ID: 20606343
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Study of standard tablet formulation based on fluidized-bed granulation.
    Sunada H; Hasegawa M; Makino T; Sakamoto H; Fujita K; Tanino T; Kokubo H; Kawaguchi T
    Drug Dev Ind Pharm; 1998 Mar; 24(3):225-33. PubMed ID: 9876579
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Drug release behavior of beads and microgranules of chitosan.
    Gupta KC; Ravi Kumar MN
    Biomaterials; 2000 Jun; 21(11):1115-9. PubMed ID: 10817263
    [TBL] [Abstract][Full Text] [Related]  

  • 54. In vitro aceclofenac release from IPN matrix tablets composed of chitosan-tamarind seed polysaccharide.
    Jana S; Sen KK; Basu SK
    Int J Biol Macromol; 2014 Apr; 65():241-5. PubMed ID: 24463265
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Biopharmaceutical evaluation of diclofenac sodium controlled release tablets prepared from gum karaya--chitosan polyelectrolyte complexes.
    Lankalapalli S; Kolapalli RM
    Drug Dev Ind Pharm; 2012 Jul; 38(7):815-24. PubMed ID: 22087874
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Usage of chitosan as a pharmaceutical material effectiveness as an additional additives of sodium alginate].
    Miyazaki T; Komuro T; Yomota C; Okada S
    Eisei Shikenjo Hokoku; 1990; (108):95-7. PubMed ID: 1364368
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chitosan microcapsules as controlled release systems for insulin.
    Aiedeh K; Gianasi E; Orienti I; Zecchi V
    J Microencapsul; 1997; 14(5):567-76. PubMed ID: 9292433
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Formulation and in vitro assessment of sustained release terbutaline sulfate tablet made from binary hydrophilic polymer mixtures.
    Al-Akayleh F; Al Remawi M; Rashid I; Badwan A
    Pharm Dev Technol; 2013; 18(5):1204-12. PubMed ID: 21977992
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A comparative study of dissolution characteristics of polymeric and wax granulations of theophylline and their tablets.
    Uhumwangho MU; Okor RS
    Pak J Pharm Sci; 2008 Jul; 21(3):230-6. PubMed ID: 18614417
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative in vitro and in vivo evaluation of matrix, osmotic matrix, and osmotic pump tablets for controlled delivery of diclofenac sodium.
    Rani M; Mishra B
    AAPS PharmSciTech; 2004 Aug; 5(4):e71. PubMed ID: 15760068
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.